MedinCell S.A.
MEDCL.PA · PAR
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | – | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | -27.9% | 70.7% | 150.6% | – |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 0% | 100% | 100% | 91.3% |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | -127.5% | -24.5% | -76.9% | -306.8% |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | -138.5% | -24% | -154.4% | -448.3% |
| EPS Diluted | -0.49 | -0.12 | -0.5 | -0.58 |
| % Growth | -308.3% | 76% | 13.8% | – |
| Operating Cash Flow | -€0 | -€0 | €0 | -€0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€0 | -€0 | €0 | -€0 |